Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,637 | 140,985 | 72,778 | 141,714 | 195,734 |
| Marketable Securities | 503,525 | 478,993 | 451,290 | 509,199 | 439,609 |
| Receivables | 115,318 | 95,357 | 71,964 | 57,406 | 54,097 |
| Inventories | 10,798 | 12,018 | 13,010 | 10,864 | 6,054 |
| Other current assets | 22,954 | 21,455 | 24,150 | 18,594 | 18,900 |
| TOTAL | $819,232 | $748,808 | $633,192 | $737,777 | $714,394 |
| Non-Current Assets | |||||
| PPE Net | 40,302 | 39,623 | 36,661 | 33,869 | 28,618 |
| Investments And Advances | 253,708 | 223,868 | 233,089 | 216,028 | 185,257 |
| Other Non-Current Assets | 66,693 | 54,562 | 54,781 | 5,477 | 5,477 |
| TOTAL | $360,703 | $318,053 | $324,531 | $255,374 | $219,352 |
| Total Assets | $1,179,935 | $1,066,861 | $957,723 | $993,151 | $933,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 383,647 |
| Accounts payable and accrued liabilities | 102,357 | 95,027 | 68,280 | 86,377 | 72,022 |
| Other current liabilities | 13,295 | 5,562 | 3,723 | 1,856 | 731 |
| TOTAL | $115,652 | $100,589 | $72,003 | $88,233 | $456,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 403,589 | 398,466 | 393,435 | 388,496 | 0 |
| Other Non-Current Liabilities | 86,179 | 84,100 | 83,010 | 35,657 | 12,107 |
| TOTAL | $489,768 | $482,566 | $476,445 | $424,153 | $29,833 |
| Total Liabilities | $605,420 | $583,155 | $548,448 | $512,386 | $486,233 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,094 | 91,579 | 91,287 | 90,821 | 90,682 |
| Common Shares | 92 | 92 | 91 | 91 | 91 |
| Retained earnings | -1,166,700 | -1,220,489 | -1,271,827 | -1,177,755 | -1,195,833 |
| Other shareholders' equity | 1,606 | 645 | -233 | -1,932 | -2,056 |
| TOTAL | $574,515 | $483,706 | $409,275 | $480,765 | $447,513 |
| Total Liabilities And Equity | $1,179,935 | $1,066,861 | $957,723 | $993,151 | $933,746 |